Prostate cancer screening

Primary Care - Clinics in Office Practice

Volumn 41, Issue 2, 2014, Pages 355-370

  Ragsdale, John W ^a   Halstater, Brian ^a   Martinez Bianchi, Viviana ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Digital rectal examination; DRE; Prostate cancer; Prostate specific antigen; PSA; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE; BLACK PERSON; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; DIGITAL RECTAL EXAMINATION; ELECTRONIC MEDICAL RECORD; FAMILY HISTORY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; LAW; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MORTALITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; RACE; RACE DIFFERENCE; REVIEW; RISK BENEFIT ANALYSIS; UNITED STATES; DECISION SUPPORT SYSTEM; EARLY DIAGNOSIS; MALE; ORGANIZATION AND MANAGEMENT; PATIENT PARTICIPATION; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PROCEDURES; PROSTATIC NEOPLASMS; RISK FACTOR;

DECISION SUPPORT TECHNIQUES; EARLY DETECTION OF CANCER; HUMANS; MALE; PATIENT PARTICIPATION; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84900018323     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2014.02.009     Document Type: Review

References (58)

1. American Cancer Society. Prostate cancer. 2013. Available at:. Accessed January 4, 2014. http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-key-statistics.
2. National Cancer Institute at the National Institutes of Health. Prostate cancer. Available at:. Accessed January 4, 2014. http://www.cancer.gov/cancertopics/types/prostate.
3. American Cancer Society. Lifetime risk of developing or dying from cancer. 2013. Available at:. Accessed January 4, 2014. http://www.cancer.org/cancer/cancerbasics/lifetime-probability-of-developing-or-dying-from-cancer.
4. US Preventive Services Task Force. Screening for prostate cancer. 2012. Available at:. Accessed January 4, 2014. http://www.uspreventiveservicestaskforce.org/prostatecancerscreening.htm.
5. National Cancer Institute. SEER cancer statistics factsheets: prostate cancer. Available at:. http://seer.cancer.gov/statfacts/html/prost.html.
6. Centers for Disease Control and Prevention. US cancer statistics: 2010 cancer types grouped by race and ethnicity. Available at:. Accessed January 4, 2014. http://apps.nccd.cdc.gov/uscs/cancersbyraceandethnicity.aspx.
7. Barocas D.A., Penson D.F. Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap. BJU Int 2010, 106(3):322-328.
8. Hudson M.A., Luo S., Chrusciel T., et al. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?. Urol Oncol 2014, 32(1):34.e9-34.e18.
9. Barocas D.A., Gray D.T., Fowke J.H., et al. Racial variation in the quality of surgical care for prostate cancer. JUrol 2012, 188(4):1279-1285.
10. Mordukhovich I., Reiter P.L., Backes D.M., et al. Areview of African American-white differences in risk factors for cancer: prostate cancer. Cancer Causes Control 2011, 22(3):341-357.
11. Dimah K., Dimah A. Prostate cancer among African American men: a review of empirical literature. JAfr Am Stud 2003, 7(1):20.
12. Koscuiszka M., Hatcher D., Christos P.J., et al. Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatment. Cancer 2012, 118(12):3145-3152.
13. Wallace T.A., Prueitt R.L., Yi M., et al. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res 2008, 68(3):927-936.
14. Fachal L., Gómez-Caamaño A., Celeiro-Muñoz C., et al. BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data. Prostate 2011, 71(16):1768-1779.
15. Levy-Lahad E., Friedman E. Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer 2007, 96(1):11-15.
16. Kurian A.W. BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 2010, 22(1):72-78.
17. National Cancer Institute at the National Institutes of Health. BRCA1 and BRCA2: cancer risk and genetic testing. Available at:. Accessed January 4, 2014. http://www.cancer.gov/cancertopics/factsheet/Risk/BRCA.
18. National Cancer Institute at the National Institutes of Health. Genetics of prostate cancer (PDQ). Available at:. Accessed January 4, 2014. http://www.cancer.gov/cancertopics/pdq/genetics/prostate/HealthProfessional/#Reference1.21.
19. Centers for Disease Control and Prevention. Prostate cancer: what screening tests are there? 2013. Available at:. Accessed January 5, 2014. http://www.cdc.gov/cancer/prostate/basic_info/screening.htm.
20. National Cancer Institute at the National Institutes of Health. Prostate cancer screening (PDQ). Available at:. Accessed January 5, 2014. http://www.cancer.gov/cancertopics/pdq/screening/prostate/HealthProfessional/page3#Reference3.10.
21. Chodak G.W., Keller P., Schoenberg H.W. Assessment of screening for prostate cancer using the digital rectal examination. JUrol 1989, 141(5):1136-1138.
22. Carter HB, Albertsen PC, Barry MJ, etal. Early detection of prostate cancer: AUA guideline. 2013. Available at:. Accessed January 5, 2014. http://www.auanet.org/common/pdf/education/clinical-guidance/Prostate-Cancer-Detection.pdf.
23. Heidenreich A., Bastian P.J., Bellmunt J., et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 2014, 65(1):124-137.
24. Djulbegovic M., Beyth R.J., Neuberger M.M., et al. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ 2010, 341:c4543.
25. Chou R., Croswell J.M., Dana T., et al. Screening for prostate cancer: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2011, 155(11):762-771.
26. Wilt T.J., Brawer M.K., Barry M.J., et al. The Prostate cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. Contemp Clin Trials 2009, 30(1):81-87.
27. Schroder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate-cancer mortality in a randomized European study. NEngl J Med 2009, 360(13):1320-1328.
28. Pinsky P.F., Parnes H.L., Andriole G. Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial. BJU Int 2013, [Epub ahead of print].
29. US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. 2012. Available at:. Accessed January 5, 2014. http://www.uspreventiveservicestaskforce.org/prostatecancerscreening/prostatefinalrs.htm.
30. Pollack C.E., Platz E.A., Bhavsar N.A., et al. Primary care providers' perspectives on discontinuing prostate cancer screening. Cancer 2012, 118(22):5518-5524.
31. US Preventive Services Task Force. Talking with your patients about screening for prostate cancer. 2012. Available at:. Accessed January 5, 2014. http://www.uspreventiveservicestaskforce.org/prostatecancerscreening/prostatecancerscript.pdf.
32. American Society of Clinical Oncology. ASCO guidelines: decision aid tool-prostate cancer screening with PSA testing. Available at:. Accessed January 5, 2014. http://www.asco.org/sites/www.asco.org/files/psa_pco_decision_aid_71612.pdf.
33. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): prostate cancer early detection (version 2.2012). Available at:. Accessed January 5, 2014. http://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf.
34. Heidenreich A, Bastian PJ, Bellmunt J, etal. Guidelines on prostate cancer. 2013. Available at:. Accessed January 5, 2014. http://www.uroweb.org/gls/pdf/09_Prostate_Cancer_LR.pdf.
35. National Health Service. Prostate cancer-PSA screening. 2012. Available at:. Accessed January 5, 2014. http://www.nhs.uk/Conditions/Cancer-of-the-prostate/Pages/Prevention.aspx.
36. Qaseem A., Barry M.J., Denberg T.D., et al. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 2013, 158(10):761-769.
37. Wolf A.M., Wender R.C., Etzioni R.B., et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010, 60(2):70-98.
38. Han P.K., Kobrin S., Breen N., et al. National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med 2013, 11(4):306-314.
39. Elwyn G., Frosch D., Thomson R., et al. Shared decision making: a model for clinical practice. JGen Intern Med 2012, 27(10):1361-1367.
40. Lin G.A., Aaronson D.S., Knight S.J., et al. Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA Cancer J Clin 2009, 59(6):379-390.
41. O'Connor A.M., Wennberg J.E., Legare F., et al. Toward the 'tipping point': decision aids and informed patient choice. Health Aff (Millwood) 2007, 26(3):716-725.
42. Stacey D., Bennett C.L., Barry M.J., et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2011, (10). CD001431.
43. University of Texas Health Science Center San Antonio. Individualized risk assessment of prostate cancer (PCPTRC 2.0). Available at:. Accessed January 5, 2014. http://deb.uthscsa.edu/URORiskCalc/Pages/calcs.jsp.
44. Thompson I.M., Ankerst D.P., Chi C., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. JNatl Cancer Inst 2006, 98(8):529-534.
45. Rollins G. The next generation of prostate cancer diagnostics: are molecular tests ready?. Clinical Laboratory News 2013, 39(6). Available at:, Accessed January 5, 2014. http://www.aacc.org/publications/cln/2013/june/Pages/Prostate-Cancer.aspx#.
46. Garg V., Gu N.Y., Borrego M.E., et al. Aliterature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening. Expert Rev Pharmacoecon Outcomes Res 2013, 13(3):327-342.
47. American Cancer Society. Medicare coverage for cancer prevention and early detection. 2013. Available at:. Accessed January 5, 2014. http://www.cancer.org/healthy/findcancerearly/cancerscreeningguidelines/medicare-coverage-for-cancer-prevention-and-early-detection.
48. De Leon S.F., Shih S.C. Tracking the delivery of prevention-oriented care among primary care providers who have adopted electronic health records. JAm Med Inform Assoc 2011, 18(Suppl 1):i91-i95.
49. Romano M.J., Stafford R.S. Electronic health records and clinical decision support systems: impact on national ambulatory care quality. Arch Intern Med 2011, 171(10):897-903.
50. Murphy D.R., Laxmisan A., Reis B.A., et al. Electronic health record-based triggers to detect potential delays in cancer diagnosis. BMJ Qual Saf 2013, 23(1):8-16.
51. Agency for Healthcare Research and Quality. Patient centered medical home resource center. Available at:. Accessed March 18, 2014. http://pcmh.ahrq.gov/page/defining.
52. Shortell S.M., Gillies R., Wu F. United States innovations in healthcare delivery. Public Health Reviews 2010, 32(1):190-212.
53. Sarfaty M., Wender R., Smith R. Promoting cancer screening within the patient centered medical home. CA Cancer J Clin 2011, 61(6):397-408.
54. Centers for Medicare and Medicaid Services. Accountable care organizations. 2013. Available at:. Accessed January 7, 2014. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ACO/index.html?redirect=/aco/%20last%20accessed%209/4/2013.
55. Centers for Medicare and Medicaid Services. Accountable care organization 2013 program analysis: quality performance standards narrative measure specifications. 2012. Available at:. Accessed January 7, 2014. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/ACO-NarrativeMeasures-Specs.pdf.
56. Legare F., Ratte S., Gravel K., et al. Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals' perceptions. Patient Educ Couns 2008, 73(3):526-535.
57. Berwick D.M. Making good on ACOs' promise-the final rule for the Medicare shared savings program. NEngl J Med 2011, 365(19):1753-1756.
58. Pearson W.S., King D.E., Richards C. Capitated payments to primary care providers and the delivery of patient education. JAm Board Fam Med 2013, 26(4):350-355.